Indap (Indapamide)

Indapamide blocks the Na+/Cl‑ cotransporter in the distal convoluted tubule of the kidney, decreasing sodium and chloride reabsorption. This leads to increased urine output, reduced extracellular fluid volume, and lower arterial pressure. Additional vasodilatory effects further support blood‑pressure reduction.

The specific dose of Indap is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and renal function. Dosage may vary, and adjustments are made according to therapeutic goals and tolerability.

The safety of indapamide in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Indap, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class and offers a longer duration of action with a lower incidence of metabolic disturbances compared with some traditional thiazides. It is often chosen for patients who need effective blood‑pressure control while minimizing electrolyte shifts.

Indap tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Indap is taken orally, usually once daily in the morning, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include severe dehydration, electrolyte imbalances such as hyponatremia or hypokalemia, and rare blood disorders like leukopenia. Patients should be monitored for signs of dizziness, muscle cramps, or unusual bleeding, and seek medical attention promptly if these occur.

Indap is contraindicated in patients with anuria, severe renal impairment, or known hypersensitivity to indapamide or other sulfonamide derivatives. Caution is also advised for individuals with uncontrolled diabetes, gout, or severe liver disease.